Clinical Trials Logo
  1. Home
  2. Immunization
  3. NCT03705455
  4. Details
NCT03705455 Clinical Trial

Immunization Schedule Alert Platform

Immunization Clinical Trial

— ISAP  

Official title:
Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03705455
Other study ID # OPP1182651
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date December 31, 2019

Study information
Verified date October 2018
Source Lifespan Healthcare Resource Limited
Contact Emmanuel Ihedioha, MBBS
Phone 23407038861841
Email emmanuel.ihedioha@lifespanhcr.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.

Description:

The ISAP - Immunization Schedule Alert Platform study is investigating the efficacy of ISAP SMS exposure to Caregivers with children( who have fulfilled our inclusion criteria) due for routine childhood Immunisation in influencing decision for timely and complete Immunization uptake. ISAP SMS messages contains information on the Immunization appointment schedule, time ,vaccine to be administered and the address of the Immunization centre.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1800
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Weeks to 12 Months
Eligibility Inclusion Criteria:

Caregiver with child due for birth dose vaccination or at 6weeks-OPV1,Penta1,PCV1,Rota1.

Exclusion Criteria: Caregiver with child who have already had OPV1,Penta1,PCV1and Rota1.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• ISAP SMS
ISAP SMS is a text message for caregivers use that provides immunization schedule and vaccine availability at the nearest immunization clinic.

Locations
Country Name City State
Nigeria Nkanu East Health centre Immunization clinic Enugu

Sponsors (1)
Lead Sponsor Collaborator
Lifespan Healthcare Resource Limited

Country where clinical trial is conducted

Nigeria, 

Outcome
Type Measure Description Time frame Safety issue
Primary Proportion of timely and complete vaccine uptake after ISAP SMS Intervention Proportion of timely and complete vaccine uptake after ISAP SMS Intervention 12 months
See also
  Status Clinical Trial Phase
Completed NCT02526394 - Pertussis and Meningitis C Concomitant Vaccination in Adolescents Phase 4
Completed NCT01707212 - Prenatal Education About Infant Immunization Pain Management Phase 3
Completed NCT01463176 - Music Therapy as Procedural Support for Young Children Undergoing Immunizations N/A
Completed NCT01193335 - Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. Phase 4
Completed NCT04222595 - FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV N/A
Completed NCT05794113 - Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform N/A
Recruiting NCT01713322 - Testing Educational Materials in a Paediatric Setting Phase 3
Recruiting NCT01601197 - A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization Phase 3
Completed NCT01296906 - Population Versus Practice-based Interventions to Increase Immunizations N/A
Completed NCT01399814 - Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer Phase 3
Completed NCT01390363 - Study of Adolescent Immunization Recall Systems N/A
Completed NCT02609035 - Immunization Services Model for Adult Rate Improvement N/A
Recruiting NCT02200276 - Influenza Immunization in Adults Over Age 75 N/A
Completed NCT01677702 - Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization N/A
Recruiting NCT05213000 - Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress N/A
Completed NCT03188692 - Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants Phase 3
Completed NCT02432430 - Comparison of Immunization Quality Improvement Dissemination Study N/A
Completed NCT01379846 - Study of TAK-816 in Healthy Infants Phase 3
Active, not recruiting NCT03943875 - GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose Phase 4
Completed NCT02819895 - PRIMM Trial (Phone Reminder for IMMunization) N/A